The CBD Store
CBD from Yeast Librede’s platform can synthesize a variety of cannabinoids simply by substituting different enzymes into the yeast. In addition, our pathway used olivetolic acid as an intermediate, but if divarinic acid is used, the same enzymes result in cannabidivarinic acid (CBDVA) and analogous molecules. The carboxylic acid group of any of the acidic cannabinoid forms can be removed chemically or with heat, resulting in CBD, CBC, CBDV, etc. and therefore we may obtain multiple cannabinoids in a straightforward manner.

Beyond natural cannabinoids – a platform for development of novel cannabinoids Our platform is not limited to the production of natural cannabinoids from C. sativa or other cannabis species. In addition to production of natural molecules, it is also possible to create cannabinoid-like derivatives that are pharmaceutically active, new molecular entities (NMEs). This can allow chemists to better understand how cannabinoids are made and how their modification can affect binding to ECS receptors. These insights can be used to design new cannabinoid-like molecules for therapeutic effects.
By engineering additional enzymatic pathways or mutating the enzymes present in the current pathways, we are able to make compounds derived from existing cannabinoids with novel therapeutic activities and benefits. Therefore we see our innovation as both a production platform that can be scaled for pharmaceutical production but also as a drug discovery tool that can be used to create new compounds. Our platform can take cannabinoid-like molecules from initial discovery all the way to commercial products, eliminating many of the shortcomings associated with natural product drug development.
The CBD Store Sells the following brands (secure buying site) |
|